EUVIMEDEUVIMED entdecken
Open Access

Cefazolin vs Cloxacillin for Methicillin-Susceptible S aureus Bacteremia

Todd C Lee, Steven Y C Tong, Joshua S Davis, Arthur M Albuquerque, Matthew P Cheng, Jacob Dye, Nesrin Ghanem-Zoubi, Anna L Goodman, Nynke G L Jager, Achim J Kaasch, Ilse J E Kouijzer, David C Lye und 9 weitere

JAMA Network Open · 12.11.2026 · 9 (11) · e2643836

DOI: 10.1001/jamanetworkopen.2026.43836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 12.11.2026. Verfasst von Todd C Lee und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This bayesian meta-analysis of 2 randomized clinical trials synthesizes mortality and safety outcomes associated with cloxacillin vs cefazolin for treatment of methicillin-susceptible S aureus bacteremia.

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada.
  • Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Canada.
  • Victorian Infectious Diseases Service, The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Melbourne Centre for Clinical Trials, School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • School of Medicine and Public Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia.

Zitieren

APA

Lee, T. C., Tong, S. Y. C., Davis, J. S., Albuquerque, A. M., Cheng, M. P., Dye, J., Ghanem-Zoubi, N., Goodman, A. L., Jager, N. G. L., Kaasch, A. J., Kouijzer, I. J. E., Lye, D. C., McLean, A. R. D., McMullan, B. J., Paterson, D. L., Prosty, C., Roberts, J. A., Tattevin, P., Tverring, J., …, & McDonald, E. G. (2026). Cefazolin vs Cloxacillin for Methicillin-Susceptible S aureus Bacteremia. JAMA Network Open, 9(11), e2643836. https://doi.org/10.1001/jamanetworkopen.2026.43836

Vancouver

Lee TC, Tong SYC, Davis JS, Albuquerque AM, Cheng MP, Dye J, et al. Cefazolin vs Cloxacillin for Methicillin-Susceptible S aureus Bacteremia. JAMA Network Open. 2026;9(11):e2643836. doi:10.1001/jamanetworkopen.2026.43836

BibTeX
@article{Lee2026,
  author = {Lee, Todd C and Tong, Steven Y C and Davis, Joshua S and Albuquerque, Arthur M and Cheng, Matthew P and Dye, Jacob and Ghanem-Zoubi, Nesrin and Goodman, Anna L and Jager, Nynke G L and Kaasch, Achim J and Kouijzer, Ilse J E and Lye, David C and McLean, Alistair R D and McMullan, Brendan J and Paterson, David L and Prosty, Connor and Roberts, Jason A and Tattevin, Pierre and Tverring, Jonas and Yahav, Dafna and McDonald, Emily G},
  title = {Cefazolin vs Cloxacillin for Methicillin-Susceptible S aureus Bacteremia},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {11},
  pages = {e2643836},
  doi = {10.1001/jamanetworkopen.2026.43836}
}
Kostenlos starten →